A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing K

A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation ( bestow) / Estudio en fase II, multicéntrico, aleatorizado y sin enmascaramiento para evaluar la seguridad y eficacia de tegoprubart en pacientes que se someten a un trasplante de riñón. ( Bestow)

Open

Protocol code: AT-1501-K207
EudraCT code: No aplica
Research group: Nephrology and kidney transplantation
Service: Nephrology
Principal investigator: Bestard Matamoros, Oriol
Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més
Phase: Fase II